Ticagrelor vs. Clopidogrel in Acute Coronary Syndrome Patients With Chronic Kidney Disease After New-Generation Drug-Eluting Stent Implantation.

There was no significant between-group difference in the rates of bleeding events in crude analysis; however, in propensity score-matched analysis, the ticagrelor-based DAPT group showed a trend toward a higher bleeding rate than the clopidogrel-based DAPT group ( Figures 3C,D and Table 2 ).

also in 53,322 other papers